May 12, 2022
Video
An expert panel shares insight on the future treatment landscape for treatment-resistant depression.
Dr Martin Rosenzweig discusses the importance of data collection to improve patient care in treatment-resistant depression, as well as alternative payment models.
May 05, 2022
Drs Martin Rosenzweig and Samuel Nordberg share perspectives for integrated policymaking in behavioral health, as well as payer and provider collaboration for treatment-resistant depression.
Carrie Jardine leads a discussion on varying prior authorization policies for alternative therapies for treatment-resistant depression along with implications to patients.
New Promising Phase 3 Bimekizumab Data Among Patients with Psoriatic Arthritis
TNF-Antagonist Therapy Linked to Better Outcomes for Post-Operative Crohn’s Disease
DDW Research Shows No Efficacy for Vedolizumab in Treating NAFLD